Concepedia

Author

Daniel Stadlbauer

Icahn School of Medicine at Mount SinaiORCID

Also Known As

Ariel Raskin, Bernard Khor, D. Stadlbauer, Daniel Stadlbauer, Giulio Kleiner, Hiroki Kimura, Levy A. Sominsky, Meagan McMahon, Morgan van Kesteren, Stadlbauer, Daniel

82

Publications

9.9K

Citations

36

H-Index

28

Concepts

All Affiliations

Icahn School of Medicine at Mount SinaiBOKU UniversityModerna Therapeutics (United States)Washington University in St. LouisScripps Research Institute
DS

About

Daniel Stadlbauer is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

19

2.9K

2

Immunology

14

15

2.5K

3

Epidemiology

10

10

868

4

Public Health

3

3

242

5

Allergy

1

1

14

Daniel Stadlbauer

×

49

Publications

9.1K

Citations

33

H-Index

YearCitations

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier,

Nature Medicine

2020

1.9K

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg, Fatima Amanat, Adolfo Firpo,

Science

2020

1.2K

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Daniel Stadlbauer, Fatima Amanat, Veronika Chromikova,

Current Protocols in Microbiology

2020

805

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer, Komal Srivastava, Hala Alshammary,

New England Journal of Medicine

2021

793

Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study

Sean Liu, Hung-Mo Lin, Ian Baine,

Nature Medicine

2020

493

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier,

2020

397

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy,

Nature Medicine

2020

342

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon,

Science

2019

273

Immunological imprinting of the antibody response in COVID-19 patients

Teresa Aydillo, Alexander Rombauts, Daniel Stadlbauer,

Nature Communications

2021

231

Novel correlates of protection against pandemic H1N1 influenza A virus infection

Sophia Ng, Raffael Nachbagauer, Ángel Balmaseda,

Nature Medicine

2019

194

Page 1